{"id":58473,"date":"2026-04-24T16:46:36","date_gmt":"2026-04-24T14:46:36","guid":{"rendered":"https:\/\/setterwalls.se\/?post_type=assignments&#038;p=58473"},"modified":"2026-04-24T16:46:36","modified_gmt":"2026-04-24T14:46:36","slug":"setterwalls-has-advised-ascelia-pharma-in-connection-with-a-private-placement","status":"publish","type":"assignments","link":"https:\/\/setterwalls.se\/en\/case\/setterwalls-has-advised-ascelia-pharma-in-connection-with-a-private-placement\/","title":{"rendered":"Setterwalls has advised Ascelia Pharma in connection with a private placement"},"content":{"rendered":"    <section class=\"block text bg-white\">\n        <div class=\"container container-sm\">\n            <div class=\"row\">\n                <div class=\"col-12\">\n                    <div class=\"editor-content\">\n                                                <div class=\"--ca-790 \" aria-label=\"7. Preamble (Engelska) Text med en rad Kr\u00e4ver svar \">\n<div class=\"-CC-821 \" data-automation-id=\"questionContent\">\n<div class=\"-Oa-256 \">\n<div class=\"-VA-277\">\n<p class=\"-ER-824\"><strong>Setterwalls has advised Ascelia Pharma AB (\u201cAscelia Pharma\u201d), listed on Nasdaq Stockholm, in connection with a private placement of ordinary shares.<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"--ca-790 \" aria-label=\"8. Description (Engelska) Flerradig text Kr\u00e4ver svar \">\n<div class=\"-CC-821 \" data-automation-id=\"questionContent\">\n<div id=\"QuestionId_r2f476fbd73dc48a4b950830456506569\" class=\"-pA-266\">\n<p class=\"-xb-267\" data-automation-id=\"questionTitle\">Ascelia Pharma is a biotech company focused on orphan oncology treatments. The company develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates \u2013 Orviglance and Oncoral \u2013 in development. Ascelia Pharma has global headquarters in Malm\u00f6, Sweden, and the company\u2019s ordinary shares are listed on Nasdaq Stockholm (ticker: ACE).<\/p>\n<p>The subscribers in the private placement include a limited number of Swedish qualified investors and existing larger shareholders. The gross proceeds secure the company\u2019s funding for partnership-related transaction costs and extend the company\u2019s cash runway into 2027.<\/p>\n<\/div>\n<\/div>\n<\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":16,"featured_media":55190,"template":"","meta":{"_acf_changed":true,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":""},"class_list":["post-58473","assignments","type-assignments","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments\/58473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments"}],"about":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/types\/assignments"}],"author":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/users\/16"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media\/55190"}],"wp:attachment":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media?parent=58473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}